Sunshine Biopharma

Sunshine Biopharma Current Assets

The Current Assets of Sunshine Biopharma (SBFM) as of Oct 31, 2026 is 23.39 M USD. In the previous year, Current Assets was 25.97 M USD — a change of -9.91% (lower).

Current Assets

23.39 MUSD

YoY

-9.91%

Last updated:

Current Assets of Sunshine Biopharma is 2025 23.39 M USD. Current Assets of Sunshine Biopharma was 2024 25.97 M USD. It decreases by -9.91% lower compared to the previous year.

The Sunshine Biopharma Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
1.11 M USD
Jan 1, 2019
65,256.00 USD
Jan 1, 2020
1.03 M USD
Jan 1, 2021
2.20 M USD
Jan 1, 2022
27.31 M USD
Jan 1, 2023
24.89 M USD
Jan 1, 2024
25.97 M USD
Jan 1, 2025
23.39 M USD
The Sunshine Biopharma Current Assets history
YEARCurrent AssetsYoY
23.39 MUSD-9.91%
25.97 MUSD+4.33%
24.89 MUSD-8.87%
27.31 MUSD+1,143.71%
2.20 MUSD+114.03%
1.03 MUSD+1,472.31%
65,256.00USD-94.10%
1.11 MUSD+928.65%
107,532.00USD+80.83%
59,467.00USD+17.07%
50,798.00USD-64.58%
143,423.00USD+359.10%
31,240.00USD-76.82%
134,793.00USD+26.64%
106,437.00USD-48.74%
207,624.00USD+85.19%
112,116.00USD+11,111.60%
1,000.00USD-80.00%
5,000.00USD-66.67%
15,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sunshine Biopharma Stock analysis

What does Sunshine Biopharma do? Sunshine Biopharma Inc., based in Pointe-Claire, Quebec, is a biotechnology company focused on developing and commercializing oncology and antiviral drugs. The company employs 46 full-time staff and operates through two segments: generic prescription pharmaceuticals and over-the-counter products. It develops proprietary drugs such as Adva-27a for pancreatic cancer, K1.1 mRNA for liver cancer, and SBFM-PL4 for antiviral applications. The firm also manages subsidiaries NoraPharma Inc. and Sunshine Biopharma Canada Inc., which handle generic and OTC product portfolios respectively. Sunshine Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunshine Biopharma stock

Current Assets of Sunshine Biopharma is 23.39 M USD in 2025.

Current Assets of Sunshine Biopharma changed from 25.97 M USD to 23.39 M USD, representing a -9.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Sunshine Biopharma since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Sunshine Biopharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Sunshine Biopharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Sunshine Biopharma